Patent · US Active

Diblock copolymers and polynucleotide complexes thereof for delivery into cells

US9862792B2 · kind B2 · utility

3Cited by
24References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 13, 2016
Grant dateJan 9, 2018
Priority date
Expiry dateSep 13, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are copolymers, and methods of making and utilizing such copolymers. Such copolymers have at least two blocks: a first block that has at least one unit that is hydrophilic at physiologic pH, and a second block that has hydrophobic groups. This second block further has at least one unit with a group that is anionic at about physiologic pH. The described copolymers are disruptive of a cellular membrane, including an extracellular membrane, an intracellular membrane, a vesicle, an organelle, an endosome, a liposome, or a red blood cell. Preferably, in certain instances, the copolymer disrupts the membrane and enters the intracellular environment. In specific examples, the copolymer is endosomolytic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.